Molecular Detection

Medical Devices & EquipmentSeries BWayne, USdetect-ready.com

Latest round

Series B

Last raised

Apr 2012

Total raised

$5.2M

Investors

5

About Molecular Detection

Molecular Detection Inc. is developing and commercializing a portfolio of sample-to-answer Detect-Ready® molecular diagnostic tests for the detection of infectious diseases. The company’s first product is a ready-to-use, rapid detection panel for hospital-based MRSA screening.

Who invested in Molecular Detection

5 investors across 2 rounds

See all investors in Molecular Detection

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Apr 16, 2012

    Amount

    $1.9M

    Investors

    Locked

  2. Series C

    Oct 1, 2009

    Amount

    $3.3M

    Investors

    Locked

Questions about Molecular Detection

Who invested in Molecular Detection?

Molecular Detection has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Molecular Detection raised?

Molecular Detection has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Molecular Detection last raise money?

Molecular Detection's most recent round on record is a Series B, in Apr 2012.

What does Molecular Detection do?

Molecular Detection is a medical devices & equipment company.

Where is Molecular Detection headquartered?

Molecular Detection is headquartered in Wayne, US.

Which VCs invest in companies like Molecular Detection?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Molecular Detection's stage. Their profiles are linked below.

Raising like Molecular Detection? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.